Derm-Biome’s DB-007-5 is highly effective at treating atopic dermatitis and reducing itch in preclinical study, outperforming the current leading topical AD drug
February 26, 2025 10:00 ET
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver-based biopharmaceutical company focused on skin health and healthy ageing, is pleased to...
ViaDerma Announces Significant 2024 Achievements and International Expansion
December 10, 2024 08:00 ET
|
ViaDerma, Inc.
LOS ANGELES, Dec. 10, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM), an innovator in transdermal drug delivery and topical antibiotic products, proudly announces the completion of a...
Dermatology Collaboration and Licensing Agreements Analysis Report 2024: Detailed Review and Access to Contract Documents - Upfront, Milestone, Royalties, Company A-Z, Therapy and Technology
November 11, 2024 04:47 ET
|
Research and Markets
Dublin, Nov. 11, 2024 (GLOBE NEWSWIRE) -- The "Dermatology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Fully revised and updated, the...
ViaDerma, Inc. Reports Strong Financial Results for Q2 2024, Achieving Positive Net Income and Significant Cash Flow Growth
October 03, 2024 08:00 ET
|
ViaDerma, Inc.
ViaDerma post strong Q2 results
Triamcinolone Market to Reach $1.3 Billion, Globally, by 2033 at 3.8% CAGR: Allied Market Research
September 18, 2024 06:28 ET
|
Allied Analytics LLP
Wilmington, Delaware, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Triamcinolone Market by Type (Cream, Injection and Inhalers), Application (Eczema,...
Eucerin® Expands Eczema Relief Line with New Eczema Relief Hydrogel
September 16, 2024 07:00 ET
|
Eucerin
It's National Eczema Week, and Eucerin offers an effective solution for those living with eczema.
ViaDerma Completes First Shipment of 500,000 Units to Nigeria
September 10, 2024 08:00 ET
|
ViaDerma, Inc.
LOS ANGELES, Sept. 10, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC: VDRM), a specialty pharmaceutical company known for developing innovative transdermal drug delivery systems, is pleased to...
ViaDerma Announces Shipment of 500,000 Units of its Flagship Product to Nigeria
August 13, 2024 08:00 ET
|
ViaDerma, Inc.
LOS ANGELES, Aug. 13, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC: VDRM), a leader in innovative wound care solutions, is excited to announce that a shipment of 500,000 units of its flagship...
ViaDerma Finalizes Distribution Agreements in Dubai and Announces Six New Key Hires
August 01, 2024 08:00 ET
|
ViaDerma, Inc.
ViaDerma announces strategic new agreements to move forward its global expansion.
Dermatology Collaboration and Licensing Deals Report, 2016 to 2024, Featuring 600+ Companies and 400+ Deals
May 02, 2024 07:33 ET
|
Research and Markets
Dublin, May 02, 2024 (GLOBE NEWSWIRE) -- The "Dermatology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Dermatology Collaboration and...